نتائج البحث 161-170 من 14382 لعملية البحث عن Lou Gehrig's disease
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. A Study ...
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. Droxidopa ...
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Genes control what is inherited from a family, such as eye color or blood type. Variation in APOL1 can cause kidney disease. African Americans, Afro-Caribbeans, ...
Genetic Markers of Cardiovascular Disease in Epilepsy. Rochester, Minn. Epilepsy is a common condition which affects over 3 million people in the US. Patients ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). ... (ALS). Dominantly ...
... disease at early clinical disease, at a premotor ... ALS we aim to eventually identify immune therapies that may provide benefit in ALS. ... diseases of the optive ...
Rochester, Minn. The purpose of this study is to evaluate the impact of pitolisant on Excessive daytime sleepiness in patients with Prader-Willi syndrome. A ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these ...
... disease. Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms. Rochester, Minn. This is a prospective, non-randomized ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.